Oral Glycoprotein IIb/IIIa Antagonists: New Insights from the SYMPHONY Trial Darren K. McGuireL. Kristin Newby OriginalPaper Pages: 111 - 119
Clopidogrel and Coronary Stenting: What is the Next Question? Scott A. MooreSteven R. Steinhubl OriginalPaper Pages: 121 - 126
A Pharmacodynamic Study of Clopidogrel in Chronic Hemodialysis Patients James S. KaufmanLouis FioreGilles Perdriset OriginalPaper Pages: 127 - 131
Prevalence of Early Left Ventricular Thrombus after Primary Coronary Intervention for Acute Myocardial Infarction Aman KalraIk-Kyung Jang OriginalPaper Pages: 133 - 136
The Use of the Electrocardiogram to Identify Epicardial Coronary and Tissue Reperfusion in Acute Myocardial Infarction Mordehay VaturiYochai Birnbaum OriginalPaper Pages: 137 - 147
Temporary Reversal of Anticoagulation Using Oral Vitamin K Richard H WhiteStephen M MintonRose Hutchinson OriginalPaper Pages: 149 - 153
Drug-Induced Thrombocytopenia in the Coronary Care Unit Nicole M PatnodePritesh J Gandhi OriginalPaper Pages: 155 - 167
Epidemiology, Diagnosis, and Management of Cardiac Disease in Chronic Renal Disease Mark J SarnakAndrew S Levey OriginalPaper Pages: 169 - 180
What is the Required Reperfusion Period for Assessment of Myocardial Infarct Size Using Triphenyltetrazolium Chloride Staining in the Rat? Ernst R. SchwarzYvette SomoanoRobert A. Kloner OriginalPaper Pages: 181 - 187
Combination of a Direct Thrombin Inhibitor and a Platelet Glycoprotein IIb/IIIa Blocking Peptide Facilitates and Maintains Reperfusion of Platelet-Rich Thrombus with Alteplase Marc S SabatineThomas M TuIk-Kyung Jang OriginalPaper Pages: 189 - 196
Effect of Coronary Thrombolysis on the Plasma Concentration of Osteonectin (SPARC, BM40) in Patients with Acute Myocardial Infarction Victor L. SerebruanyDan AtarPaul A. Gurbel OriginalPaper Pages: 197 - 202